State Street Corp Durect Corp Transaction History

State Street Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $1.22 Million - $2.05 Million	-3,207,004 Reduced 80.63%	770,577 $368,000
Q1 2022 May 16, 2022	BUY	$0.55 - $0.98 $28,740 - $51,209	52,255 Added 1.33%	3,977,581 $2.67 Million
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $385,479 - $561,087	-428,311 Reduced 9.84%	3,925,326 $3.87 Million
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.61 $12,531 - $16,674	10,357 Added 0.24%	4,353,637 $5.57 Million
Q2 2021 Aug 16, 2021	BUY	$1.6 - $2.02 $572,755 - $723,103	357,972 Added 8.98%	4,343,280 $7.08 Million
Q1 2021 May 17, 2021	BUY	$1.86 - $2.87 $772,151 - $1.19 Million	415,135 Added 11.63%	3,985,308 $7.89 Million
Q4 2020 Feb 16, 2021	BUY	$1.65 - $2.43 $490,091 - $721,770	297,025 Added 9.07%	3,570,173 $7.39 Million
Q3 2020 Nov 10, 2020	BUY	$1.6 - $2.35 $242,627 - $356,358	151,642 Added 4.86%	3,273,148 $5.6 Million
Q2 2020 Aug 14, 2020	BUY	$1.33 - $2.76 $3.99 Million - $8.29 Million	3,002,105 Added 2514.3%	3,121,506 $7.24 Million
Q1 2020 May 11, 2020	BUY	$0.97 - $2.85 $115,818 - $340,292	119,401 New	119,401 $185,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.